Estimating the costs of care, quality of life, and wider societal burden due to COPD

Background

Chronic Respiratory Diseases (CRD), especially asthma and chronic obstructive pulmonary disease (COPD), are common public health problems with high prevalence and mortality rates across the world.

Although the majority of deaths and disability occur in low- and middle-income countries (LMICs), there is very little data on their true prevalence, and therefore their wider impact, in these countries.

This study builds on work from another RESPIRE project, the 4CCORD study, which is seeking to validate the research tools and methodologies used to detect CRD in the community.

Find out more about the 4CCORD study

Aim and impact

Researchers at KEM Hospital Research Centre in India will develop and assess a method to estimate the cost of illness due to COPD.

As a long-term, progressive illness, the burden on COPD patients is high, with implications for family life, work and use of health services. Designing a method to assess direct medical cost, direct non-medical cost, indirect cost and loss of productivity collectively, with reference to COPD, would be useful for informing policy decisions.

Project data

Download the project Data Management Plan